Compare Ascendis Pharma A/S (ASND) vs Fox Corp Class B (FOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Fox Corp Class B — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Fox Corp Class B trades at $55.42 (market cap $24.58B). The key difference: Fox Corp Class B is the larger of the two by market cap, and Fox Corp Class B pays a 1.05% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | FOX | |
|---|---|---|
Market Cap | $16.67B | $24.58B |
Sector | Health | Media |
52-Week High | $277.18 | $67.76 |
52-Week Low | $189.74 | $44.39 |
Enterprise Value | $17.04B | $27.94B |
Dividend Yield | — | 1.05% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →
